NCT01128998 2015-10-19Sorafenib Plus S-1 in Advanced Solid TumorsNational Health Research Institutes, TaiwanPhase 1 Completed30 enrolled
NCT01226056 2010-10-21Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular TargetsSouthern Europe New Drug OrganizationPhase 1/2 Suspended45 enrolled